For the quarter ended December 31, 2025, revenue before reimbursements dropped 11% to US$308.5 million, from US$347.3 million a year earlier. Crawford & Company recorded a net loss of US$7.2 million, or US$0.15 per diluted share for both CRD-A and CRD-B, versus net income of US$5.7 million in the prior-year quarter.
